A
Aquestive Therapeutics, Inc.
AQST · NASDAQ · Healthcare · 533M
Closing price
$4.78
+0.42% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-9.0×
Free cash flow yieldFCF yield
-9.1%
Return on equityROE
248.9%
Operating margin
-156.4%
Net debt / EBITDAbalance-sheet strength
-0.2×
Interest coverage
-4.1×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.